Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study
Brooke A. Rice, Timothy S. Naimi, Michelle T. Long
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 11, pp. 2854-2863.e2
Open Access | Times Cited: 19

Showing 19 citing articles:

An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 773-791
Open Access | Times Cited: 93
Natural history of metabolic dysfunction-associated steatotic liver disease
Vasileios Lekakis, George Papatheodoridis
European Journal of Internal Medicine (2023) Vol. 122, pp. 3-10
Closed Access | Times Cited: 64
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
David Martí‐Aguado, José Luís Calleja, Eduardo Vilar‐Gómez, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 930-940
Closed Access | Times Cited: 35
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus
Xufen Zeng, Krista A Varady, Xiangdong Wang, et al.
Metabolism (2024) Vol. 161, pp. 156028-156028
Closed Access | Times Cited: 25
Consensus Guidelines for the Diagnosis and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Adult Asian Indians with Type 2 Diabetes
Anoop Misra, Ashish Kumar, Mohammad Shafi Kuchay, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025) Vol. 19, Iss. 3, pp. 103209-103209
Closed Access | Times Cited: 2
Changes in drinking levels and metabolic dysfunction-associated steatotic liver disease: a longitudinal study from the China multi-ethnic cohort study
Ning Zhang, Jingzhong Li, Xiaofen Xie, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease
Xiangyong Hao, Hao Song, Xin Su, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake
Majd B. Aboona, Pojsakorn Danpanichkul, Vincent Chen, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 11, pp. 2456-2463
Closed Access | Times Cited: 8
Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks
Diego Martínez‐Urbistondo, Nuria Pérez-Díaz-del-Campo, Manuel F. Landecho, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 3, pp. 461-474
Open Access | Times Cited: 3
Ten reasons gastroenterologists and hepatologists should be treating obesity
Michael Camilleri, Emad El‐Omar
Gut (2023) Vol. 72, Iss. 6, pp. 1033-1038
Closed Access | Times Cited: 7
Different minimal alcohol consumption in male and female individuals with metabolic dysfunction‐associated fatty liver disease
Yixuan Zhu, Xiaoming Xu, Zhiwen Fan, et al.
Liver International (2024) Vol. 44, Iss. 3, pp. 865-875
Open Access | Times Cited: 2
A New Non-Obese Steatohepatitis Mouse Model with Cardiac Dysfunction Induced by Addition of Ethanol to a High-Fat/High-Cholesterol Diet
Seiji Shiraishi, Jinyao Liu, Yuki Saito, et al.
Biology (2024) Vol. 13, Iss. 2, pp. 91-91
Open Access | Times Cited: 2
Identification of risk groups for advanced liver fibrosis in the general population using the Fibrosis‐3 index
Kazuya Kariyama, Miwa Kawanaka, Kazuhiro Nouso, et al.
JGH Open (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 1
Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD
Ang Huang, Cailun Zou, Zhe Dai, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Exclusive liquor and cocktail consumption is associated with at‐risk fibrosis among nonheavy alcohol users with metabolic dysfunction‐associated steatotic liver disease
Peng‐Sheng Ting, Wei‐Ting Lin, Chiung‐Kuei Huang, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 48, Iss. 1, pp. 88-97
Closed Access | Times Cited: 3
Obesity management for the hepatologist—What to do, how to do it and why?
Kymberly D. Watt, Sonali Paul, Mohammad Qasim Khan, et al.
Hepatology (2023)
Closed Access | Times Cited: 2
Establishment and validation of a predictive nomogram for severe pleural effusion in liver cancer patients after hepatectomy
Junyu Zhao, Hang-Yu Lin, Cai-Fang Gong, et al.
Medicine (2024) Vol. 103, Iss. 10, pp. e36556-e36556
Open Access
Chronische Lebererkrankungen: Auch leichter Alkoholkonsum steigert das Risiko

Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 03, pp. 362-364
Closed Access
Letter: Low to moderate alcohol intake and progression of non‐alcoholic fatty liver disease
Panyao Gu, Yuanbin Liu, Shu‐Jun Wei, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 8, pp. 924-925
Open Access
Page 1

Scroll to top